Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
The JAMA paper compared outcomes in 264,758 women who had either laparoscopic or robotically assisted hysterectomy at 441 hospitals between 2007 and 2010.
"There are so many options for hysterectomies now that patients should discuss the pros and cons of all of them with their doctors," said the study's lead author, CUMC's Dr. Jason Wright.
5 new leukemia clinician-scientists have joined the Herbert Irving Comprehensive Cancer Center at NYPH/CUMC: Drs. Mark Frattini, Mark Heaney, Joseph Jurcic, Nicole Lamanna, & Todd Rosenblat.